EDAP TMS SA
FOCLNasdaq
$5.44
↓ -0.1%Jul 17 close · end-of-day
Price
1Y↑ +269.7%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$203.5M
Enterprise Value
$207.5M
P/E
—
P/S
2.9
P/B
20.1
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$70.5M
Net Income (TTM)
-$29.2M
Free Cash Flow (TTM)
—
Gross Margin
42.5%
Operating Margin
-35.0%
Net Margin
-41.5%
ROE
-289.5%
ROIC
-137.9%
Debt / Equity
1.9
Net Cash
-$4.0M
Return 1Y
+248.4%
Company profile
EDAP TMS S.A. operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.
- CEO
- Marc Oczachowski
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 230
- Website
- edap-tms.com
Management & directors
- Annen StevenSVP, Marketing & Product Mgmt.
- Mobeck Kenneth S.Chief Financial Officer
- Rhodes RyanChief Executive Officer
- Shah SanketGen Counsel & Corp Secretary
Roles derived from SEC Form 4 filings.
Earnings
FOCL Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$17.8M↑ +24.8%
Diluted EPS-$0.24↑ +20.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $69.4M | $70.5M |
| Gross profit | — | — | — | — | $28.7M | $30.0M |
| Operating income | — | — | — | — | -$22.2M | -$24.7M |
| Net income | — | — | — | — | -$20.6M | -$29.2M |
| Diluted EPS | — | — | — | — | -$0.55 | -$0.78 |
| Operating cash flow | — | — | — | — | -$14.7M | -$16.4M |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | — | — | — | — | 41.4% | 42.5% |
| Operating margin | — | — | — | — | -32.0% | -35.0% |
| Net margin | — | — | — | — | -29.7% | -41.5% |
| Line item | Q1 '25 | Q1 '26 |
|---|---|---|
| Revenue | $14.3M | $17.8M |
| Gross profit | $6.0M | $8.1M |
| Operating income | -$6.3M | -$7.4M |
| Net income | -$7.4M | -$9.1M |
| Diluted EPS | -$0.20 | -$0.24 |
| Operating cash flow | -$5.3M | -$3.0M |
| Free cash flow | — | — |
| Gross margin | 42.0% | 45.7% |
| Operating margin | -44.2% | -41.4% |
| Net margin | -52.2% | -51.0% |
Company news
Jul 19, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-12 | Annen Steven· SVP, Marketing & Product Mgmt. | Award | 90,000 | $0.00 | $0.00 | filing |
| 2026-05-12 | Shah Sanket· Gen Counsel & Corp Secretary | Award | 67,500 | $0.00 | $0.00 | filing |
| 2026-05-12 | Rhodes Ryan· Chief Executive Officer | Award | 304,500 | $0.00 | $0.00 | filing |
| 2026-05-12 | Mobeck Kenneth S.· Chief Financial Officer | Award | 120,000 | $0.00 | $0.00 | filing |
| 2026-05-11 | LEVINE JOSHUA | Buy | 10,000 | $4.22 | $42,200.00 | filing |
Latest 5 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.